Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens
- PMID: 6155612
- DOI: 10.1056/NEJM198007243030401
Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens
Abstract
We studied the influence of preimmunization antibody level on the immune response of adults to one of two structurally related yet immunologically distinct type-specific polysaccharides from Type III Group B streptococcus and Type 14 pneumonococcus. Four weeks after immunization with multivalent pneumococcal vaccine, 20 subjects with low levels of antibody to Type III Group B streptococcus antigen had no significant increase in antibody to this antigen (P greater than 0.05), but all volunteers with moderate to high preimmunization antibody levels who were immunized with Pneumovax had significant increases (P less than 0.01). However, the streptococcal antibody response to pneumococcal Type 14 antigen was weaker and briefer than that in 10 adults given Type III Group B streptococcus vaccine(P less than 0.05). Preimmunization antibody levels influenced the immune response to a structurally similar polysaccharide antigen, but specific Type III polysaccharide antigen appeared necessary to induce a primary antibody response in "nonimmune" adults. We conclude that immunization of mothers with pneumococcal vaccine is not likely to prevent neonatal Type III Group B streptococcal infection, despite immunologic similarities between the two organisms.
Similar articles
-
Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.N Engl J Med. 1988 Nov 3;319(18):1180-5. doi: 10.1056/NEJM198811033191802. N Engl J Med. 1988. PMID: 3050524
-
Pneumococcal polysaccharide immunization of children with sickle cell disease. II. Serologic response and pneumococcal disease following immunization.Am J Pediatr Hematol Oncol. 1982 Spring;4(1):25-35. Am J Pediatr Hematol Oncol. 1982. PMID: 7091574
-
Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.J Immunol. 1990 May 15;144(10):3770-8. J Immunol. 1990. PMID: 2110213
-
Group B streptococcal vaccines.Rev Infect Dis. 1985 Jul-Aug;7(4):458-67. doi: 10.1093/clinids/7.4.458. Rev Infect Dis. 1985. PMID: 3898306 Review.
-
Chemistry and immunochemistry of the pneumococcal polysaccharide vaccine with special reference to cross-reactions and immunologic factors.Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S18-30. doi: 10.1093/clinids/3.supplement_1.s18. Rev Infect Dis. 1981. PMID: 7025157 Review.
Cited by
-
Cross-reacting human and rabbit antibodies to antigens of Histoplasma capsulatum, Candida albicans, and Saccharomyces cerevisiae.Infect Immun. 1985 Jun;48(3):806-12. doi: 10.1128/iai.48.3.806-812.1985. Infect Immun. 1985. PMID: 3888844 Free PMC article.
-
Mouse protection assay for group B streptococcus type III.Infect Immun. 1982 Jan;35(1):240-7. doi: 10.1128/iai.35.1.240-247.1982. Infect Immun. 1982. PMID: 6172381 Free PMC article.
-
Control of Streptococcal Infections: Is a Common Vaccine Target Achievable Against Streptococcus agalactiae and Streptococcus pneumoniae.Front Microbiol. 2021 Apr 23;12:658824. doi: 10.3389/fmicb.2021.658824. eCollection 2021. Front Microbiol. 2021. PMID: 33967998 Free PMC article. Review.
-
Measurement of human antibodies to type III group B Streptococcus.Infect Immun. 1999 Aug;67(8):4303-5. doi: 10.1128/IAI.67.8.4303-4305.1999. Infect Immun. 1999. PMID: 10447392 Free PMC article. No abstract available.
-
Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide.J Clin Invest. 1983 Jul;72(1):260-9. doi: 10.1172/jci110965. J Clin Invest. 1983. PMID: 6192144 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical